JPS54138126A - Remedy for diabetes - Google Patents
Remedy for diabetesInfo
- Publication number
- JPS54138126A JPS54138126A JP4501478A JP4501478A JPS54138126A JP S54138126 A JPS54138126 A JP S54138126A JP 4501478 A JP4501478 A JP 4501478A JP 4501478 A JP4501478 A JP 4501478A JP S54138126 A JPS54138126 A JP S54138126A
- Authority
- JP
- Japan
- Prior art keywords
- diabetes
- remedy
- butanediol
- remarkably effective
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 4
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: To provide a remedy for diabetes having low side effects and remarkably effective even by oral administration, containing L-1,3-butanediol.
CONSTITUTION: A remedy for diabetes containing L-1,3-butanediol (L-BD) as an active component. The L-BD has far better blood sugar leveldepressing activity than the D-BD and DL-BD, has even sugar production lowering activity, and is remarkably effective to the initial or terminal diabetes. The L-BD can be prepared by the LiH-reduction of L-3-hydroxubutyric acid which is obtained by the asymmetric reduction of methyl acetoacetate with a tartaric acid-modified Ni-catalyst.
COPYRIGHT: (C)1979,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4501478A JPS54138126A (en) | 1978-04-17 | 1978-04-17 | Remedy for diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4501478A JPS54138126A (en) | 1978-04-17 | 1978-04-17 | Remedy for diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS54138126A true JPS54138126A (en) | 1979-10-26 |
Family
ID=12707494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4501478A Pending JPS54138126A (en) | 1978-04-17 | 1978-04-17 | Remedy for diabetes |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS54138126A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428066A (en) * | 1989-03-08 | 1995-06-27 | Larner; Joseph | Method of reducing elevated blood sugar in humans |
| JP2001515510A (en) * | 1997-03-17 | 2001-09-18 | ビーティージー・インターナショナル・リミテッド | Therapeutic composition |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| US9211275B2 (en) | 2008-01-04 | 2015-12-15 | Isis Innovation Ltd. | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US9579302B2 (en) | 2012-11-05 | 2017-02-28 | Tdeltas | Ketone bodies to protect tissues from damage by ionizing radiation |
| US10660958B2 (en) | 2010-02-22 | 2020-05-26 | Tdeltas Limited | Nutritional composition |
| US10821062B2 (en) | 2013-03-12 | 2020-11-03 | Tdeltas Limited | Compound for use in protecting skin |
| US11230722B2 (en) | 2003-06-03 | 2022-01-25 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
| US11566268B2 (en) | 2013-03-14 | 2023-01-31 | Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate |
-
1978
- 1978-04-17 JP JP4501478A patent/JPS54138126A/en active Pending
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428066A (en) * | 1989-03-08 | 1995-06-27 | Larner; Joseph | Method of reducing elevated blood sugar in humans |
| JP2001515510A (en) * | 1997-03-17 | 2001-09-18 | ビーティージー・インターナショナル・リミテッド | Therapeutic composition |
| EP1017379A4 (en) * | 1997-03-17 | 2007-01-24 | Btg Int Ltd | Therapeutic compositions |
| JP2009173677A (en) * | 1997-03-17 | 2009-08-06 | Btg Internatl Ltd | Composition for therapy |
| EP2283834A3 (en) * | 1997-03-17 | 2012-02-01 | BTG International Limited | Therapeutic compositions comprising ketone bodies or their precursors |
| JP2015042644A (en) * | 1997-03-17 | 2015-03-05 | ビーティージー・インターナショナル・リミテッド | Therapeutic compositions |
| US11230722B2 (en) | 2003-06-03 | 2022-01-25 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
| US9211275B2 (en) | 2008-01-04 | 2015-12-15 | Isis Innovation Ltd. | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US11311509B2 (en) | 2008-01-04 | 2022-04-26 | Oxford University Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US10154982B2 (en) | 2008-01-04 | 2018-12-18 | Oxford University Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
| US10051880B2 (en) | 2008-08-21 | 2018-08-21 | Oxford University Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| US8642654B2 (en) | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| US10660958B2 (en) | 2010-02-22 | 2020-05-26 | Tdeltas Limited | Nutritional composition |
| US11571479B2 (en) | 2010-02-22 | 2023-02-07 | Tdeltas | Nutritional composition |
| US10478415B2 (en) | 2012-11-05 | 2019-11-19 | Tdeltas Limited | Ketone bodies to protect tissues from damage by ionizing radiation |
| US11234953B2 (en) | 2012-11-05 | 2022-02-01 | Tdeltas Limited | Ketone bodies to protect tissues from damage by ionizing radiation |
| US9579302B2 (en) | 2012-11-05 | 2017-02-28 | Tdeltas | Ketone bodies to protect tissues from damage by ionizing radiation |
| US10821062B2 (en) | 2013-03-12 | 2020-11-03 | Tdeltas Limited | Compound for use in protecting skin |
| US12377032B2 (en) | 2013-03-12 | 2025-08-05 | Tdeltas Limited | Compound for use in protecting skin |
| US11566268B2 (en) | 2013-03-14 | 2023-01-31 | Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
| JPS5771377A (en) | Sweetening agent having low cariogenicity | |
| JPS52130996A (en) | Malt preparation | |
| PT66789A (en) | Process for the preparation of pharmaceutical compositions having high rate of resorption,from heart glicosides,in se hardly resorptive,to be parenterically administered | |
| JPS54138126A (en) | Remedy for diabetes | |
| JPS5721320A (en) | Blood sugar level depressing agent | |
| JPS5244222A (en) | Method of making insulin preparations for rectal application | |
| JPS51144733A (en) | A remedy for hepatic failure | |
| JPS5318529A (en) | Optically active mandelic acid phenylglycinol salt and its preparation | |
| JPS55122715A (en) | Antidiabetic agent | |
| JPS5326316A (en) | Drug containing active vitamin d3 derivatives and its preparation | |
| JPS53148595A (en) | Preparation of salinomycines | |
| JPS5495737A (en) | Stabilized composition containing carpronium chloride | |
| JPS51144732A (en) | A remedy for hepatic failure | |
| JPS5334752A (en) | Preparation of gamma-ionones and their derivatives | |
| JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
| JPS5283923A (en) | Insulin composition for rectal infusion | |
| JPS5420127A (en) | Solid nifedipine preparaton | |
| JPS5283413A (en) | Preparation of 3,3-dimethyl-4-pentenoic acid or its esters | |
| JPS536417A (en) | Insulin composition for rectal infusion | |
| JPS5424847A (en) | Optical active methionine-mandelic acid complex and its preparation | |
| JPS5498339A (en) | Carcinostatic agent | |
| JPS5331623A (en) | Preparation of optically active sulfoximines | |
| JPS5341478A (en) | Preparation of yeast cells | |
| JPS53149939A (en) | Novel benzyl alcohol derivatives and their preparation |